Resources Contact Us Home
Lachance; Nicholas
Pierrefonds, CA
No. of patents:

Patent Number Title Of Patent Date Issued
7429666 Pyridine analogs as C5a antagonists September 30, 2008
The present invention provides novel compounds of Formula I which are antagonists of the C5a receptor. Compounds of the present invention are useful for the treatment of various C5a-mediated diseases and disorders; accordingly the present invention provides a method for the treatment of
6211197 Prostaglandin receptor ligands April 3, 2001
Compounds and methods for treating prostaglandin mediated diseases, and certain pharmaceutical compositions thereof are disclosed. The compounds are represented by formula II:The compounds of the invention are structurally different from NSAIDs and opiates, and are antagonists of the pai

  Recently Added Patents
Imaging lens having five lens elements, and electronic apparatus having the same
System and method for a TCP mapper
Measurement protocol for a medical technology apparatus
Sensor interface engineering
Native NAD-dependent GAPDH replaced with NADP-dependent GAPDH plus NADK
Tunnel magnetoresistance read head with narrow shield-to-shield spacing
Arrangements and method relating to communication bearers
  Randomly Featured Patents
Karaoke apparatus and method for displaying mixture of lyric words and background scene in fade-in and fade-out manner
Treated polyetherurethane photopolymer composition containing triaryl phosphine
Endocrine modulation with positive modulators of AMPA type glutamate receptors
Radio-frequency identification system, method of carrying out radio-frequency identification, and program for radio-frequency identification
LCD and projection type display using same
Switch control system and method that distinguishes between a plurality of real and emulated input devices
Method for operating a steam turbine with an overload valve
Preparation of surfactants
Complementary SOI lateral bipolar for SRAM in a low-voltage CMOS platform
Tool and method for fine machining work pieces